首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of neuromuscular diseases

缩写:

ISSN:2214-3599

e-ISSN:2214-3602

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引674
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Linda Remijn-Nelissen,Martijn R Tannemaat,Jan Jgm Verschuuren Linda Remijn-Nelissen
Background: Understanding treatment patterns in myasthenia gravis (MG) is crucial for clinical practice. However, longitudinal data are limited. Objective...
Annemieke Aartsma-Rus Annemieke Aartsma-Rus
Duchenne muscular dystrophy (DMD) is a muscle wasting disease where patients lose muscle tissue and function. The disease is caused by pathogenic variants that abolish the production of functional dystrophin protein. There are many therapeu...
Sara S Ali,Pankaj B Agrawal Sara S Ali
Congenital disorders are a significant contributor to neonatal intensive care unit (NICU) admissions and neonatal mortality, adding to substantial healthcare costs and emotional burden for families. The introduction of rapid next-generation...
Marta Ruggiero,Gabriele Giannotta,Giulia Morleo et al. Marta Ruggiero et al.
Objective: This scoping review aims to explore and map the most frequently reported limitations in activities of daily living (ADLs) among individuals with spinal muscular atrophy (SMA), with the goal of informing clinica...
Claudia Weiß,Katharina Vill,Matthias Baumann et al. Claudia Weiß et al.
BackgroundSince the approval of onasemnogen abeparvovec (OA) for gene addition therapy in children with spinal muscular atrophy (SMA), there has been a considerable increase of evidence regarding its effectiveness and safety. Consequently, ...
Sylvie Benchetrit,Céline Chu,Dimitrios Athanasiou et al. Sylvie Benchetrit et al.
BackgroundDuchenne muscular dystrophy (DMD) is a severe muscle disease with an unmet therapeutic need. Despite ongoing research efforts, only a few medicines have achieved marketing authorisation in the EU to date. We present a regulatory s...
Beatrice Labella,Guy Brochier,Maud Beuvin et al. Beatrice Labella et al.
Pathogenic variants in the MYH2 gene are associated with congenital myopathy. We report 13 unrelated patients and a systematic review of published cases through 30 October 2024, supplemented by HGMD Pro (2024.2) and LOVD (https://www.lovd.n...
Hacer Durmuş,Christoph S Clemen,Evren Önay Uçar et al. Hacer Durmuş et al.
Homozygous KY variants have been described to cause congenital myopathy, myofibrillar myopathy type 7, and hereditary spastic paraplegia. We report the findings in two families harboring the homozygous missense NM_178554.4:c.727T > C p.(Cys...
Lola Er Lessard,Danielle K Bourque,Pierre J Bourque et al. Lola Er Lessard et al.
BackgroundHereditary spastic paraplegia (HSP) is a heterogenous group of rare genetic disorders characterized by progressive corticospinal and dorsal spinal cord axonal degeneration manifesting as muscle weakness and spasticity of the lower...